Possible Hypoxia Signaling Induced Alteration of Glucose Homeostasis in Rats Exposed to Chronic Intermittent Hypoxia - Role of Antioxidant (Vitamin C) and Ca2+ Channel Blocker (Cilnidipine)
Journal:
Current Signal Transduction Therapy
Volume:
11
Page:
49-55
Author(s):
Kusal K. Das, Santosh R. Nemagouda, Satish G. Patil and Sikha Saha
Diabetic Bone Fracture Repair: A Progenitor Cell-Based Paradigm
Journal:
Current Stem Cell Research & Therapy
Volume:
11
Page:
494-504
Author(s):
Jessica S. Hayes and Cynthia M. Coleman
Venous Thromboembolism Risk and Adequacy of Prophylaxis in High Risk Pregnancy in the Arabian Gulf
Journal:
Current Vascular Pharmacology
Volume:
14
Page:
368-373
Author(s):
Faisal Alsayegh, Waleed Al-Jassar, Salima Wani, Muna Tahlak, Awatef Albahar, Lamya Al Kharusi, Halima Al-Tamimi, Faten El-Taher, Naeema Mahmood and Ibrahim Al-Zakwani
Editorial: The New Trial EMPAREG-OUTCOMES in Type 2 Diabetes: “and Death Shall Have no Dominion”?
Journal:
Current Vascular Pharmacology
Volume:
14
Page:
316-318
Author(s):
Nikolaos Papanas, Costas Tsioufis and Efstratios S. Maltezos
Effects of Antiplatelet Medication on Arteriovenous Fistula Patency After Surgical Thrombectomy
Journal:
Current Vascular Pharmacology
Volume:
14
Page:
353-359
Author(s):
Chi-Hsiao Yeh, Ting-Shuo Huang, Yao-Chang Wang, Pin-Fu Huang, Tzu-Yen Huang, Tzu-Ping Chen, Shun-Ying Yin and Yu-Wei Yu
Control of Risk Factors for Cardiovascular Disease among Multinational Patient Population in the Arabian Gulf
Journal:
Current Vascular Pharmacology
Volume:
14
Page:
374-381
Author(s):
Mohammed Fakhry, Khalid Al-Rasadi, Khamis Al-Hashmi, Khalid Al-Waili, Raul D. Santos, Haitham Amin, Fahad O.A.S. Baslaib, Omar Al-Hallaq, Obaid Al-Jassim, Afzal H. Yusufali, Abdel R. Medani, Hossam Elghetany, Ibrahim Al-Zakwani, Akram Al-Khadra, Othman Metwally, Khalid Al-Nemer, Faisal Al-Anazi, Shorook Al-Herz, Mahmoud Al-Awadhi, Omer Al-Tamimi, Abdullah Shehab, Ali T. Al-Hinai, Mohamed Arafah and Wael Al-Mahmeed
Impact of Polypharmacy on Adherence to Evidence-Based Medication in Patients who Underwent Percutaneous Coronary Intervention
Journal:
Current Vascular Pharmacology
Volume:
14
Page:
388-393
Author(s):
Shaban Mohammed, Abdulrahaman Arabi, Ayman El-Menyar, Sabir Abdulkarim, Amer AlJundi, Awad Alqahtani, Salah Arafa and Jassim Al Suwaidi
Editorial: MicroRNA-33 Inhibition: A Potential Adjunct to Statin Therapy?
Journal:
Current Vascular Pharmacology
Volume:
14
Page:
321-322
Author(s):
Amirhossein Sahebkar, Pamela Maffioli, Maciej Banach and Giuseppe Derosa
Editorial: Resolution of Non-Alcoholic-Steatohepatitis. More than One Drug Needed?
Journal:
Current Vascular Pharmacology
Volume:
14
Page:
313-315
Author(s):
Vasilios G. Athyros, Niki Katsiki and Dimitri P. Mikhailidis
Regular Physical Activity and Vascular Aging
Journal:
Current Pharmaceutical Design
Volume:
22
Page:
3715-3729
Author(s):
Bárbara M.M. Antunes, Fabrício E. Rossi, Jason M. Cholewa and Fábio S. Lira